Amentum (NYSE:AMTM) Stock Rating Raised to Neutral at BNP Paribas Exane

Key Points

• BNP Paribas Exane upgraded Amentum from “underperform” to “neutral” and set a $20 price target, implying 9.35% upside from the previous close.
• Analyst sentiment remains broadly cautious: five analysts rate the stock a Buy, seven a Hold, and one a Sell, with a consensus target price of $29.
• Amentum’s latest quarter beat EPS expectations ($0.67 versus $0.61) but missed revenue estimates, while revenue declined 2% year over year; shares opened at $18.29, near their 52-week low.

Amentum (NYSE:AMTM - Get Free Report) was upgraded by stock analysts at BNP Paribas Exane from an "underperform" rating to a "neutral" rating in a note issued to investors on Tuesday, Marketbeat.com reports. The firm currently has a $20.00 price target on the stock. BNP Paribas Exane's target price suggests a potential upside of 9.35% from the stock's previous close.

A number of other brokerages have also recently commented on AMTM. Morgan Stanley set a $24.00 price objective on Amentum in a research note on Tuesday, August 11th. Zacks Research downgraded shares of Amentum from a "hold" rating to a "strong sell" rating in a research report on Thursday, October 1st. JPMorgan Chase & Co. reduced their price objective on shares of Amentum from $31.00 to $26.00 and set a "neutral" rating on the stock in a research note on Monday, August 17th. Royal Bank Of Canada decreased their price objective on shares of Amentum from $28.00 to $26.00 and set a "sector perform" rating for the company in a report on Wednesday, August 12th. Finally, Bank of America cut their target price on shares of Amentum from $35.00 to $30.00 and set a "neutral" rating on the stock in a report on Monday, July 20th. Five analysts have rated the stock with a Buy rating, seven have issued a Hold rating and one has assigned a Sell rating to the stock. According to data from MarketBeat.com, the company has an average rating of "Hold" and a consensus target price of $29.00.

Amentum Trading Up 0.8%

AMTM opened at $18.29 on Tuesday. The company has a debt-to-equity ratio of 0.79, a current ratio of 1.52 and a quick ratio of 1.52. The company has a market cap of $4.47 billion, a price-to-earnings ratio of 22.04, a price-to-earnings-growth ratio of 0.49 and a beta of 0.31. The firm has a 50 day simple moving average of $20.67 and a 200 day simple moving average of $22.69. Amentum has a fifty-two week low of $17.72 and a fifty-two week high of $38.11.

Amentum (NYSE:AMTM - Get Free Report) last announced its quarterly earnings data on Monday, August 10th. The company reported $0.67 earnings per share (EPS) for the quarter, beating analysts' consensus estimates of $0.61 by $0.06. The firm had revenue of $3.49 billion for the quarter, compared to analysts' expectations of $3.57 billion. Amentum had a net margin of 1.44% and a return on equity of 12.19%. The business's revenue for the quarter was down 2.0% on a year-over-year basis. During the same period last year, the firm earned $0.56 earnings per share. Amentum has set its FY 2026 guidance at 2.400-2.500 EPS. On average, sell-side analysts anticipate that Amentum will post 2.38 earnings per share for the current year.

Hedge Funds Weigh In On Amentum

A number of institutional investors and hedge funds have recently added to or reduced their stakes in the stock. BlackRock Inc. bought a new stake in Amentum in the 2nd quarter valued at approximately $370,137,000. Primecap Management Co. CA bought a new stake in shares of Amentum in the second quarter worth $253,941,000. Dimensional Fund Advisors LP lifted its position in shares of Amentum by 106.6% in the first quarter. Dimensional Fund Advisors LP now owns 3,787,420 shares of the company's stock worth $98,767,000 after purchasing an additional 1,954,494 shares in the last quarter. Focus Partners Wealth boosted its holdings in Amentum by 8,467.6% during the fourth quarter. Focus Partners Wealth now owns 2,794,417 shares of the company's stock worth $81,038,000 after purchasing an additional 2,761,801 shares during the last quarter. Finally, Troluce Capital Advisors LLC grew its position in Amentum by 256.5% in the second quarter. Troluce Capital Advisors LLC now owns 3,565,399 shares of the company's stock valued at $73,697,000 after purchasing an additional 2,565,399 shares in the last quarter. 39.93% of the stock is owned by institutional investors and hedge funds.

About Amentum

Amentum NYSE: AMTM is a global engineering and technical services contractor that supports government and commercial customers across defense, intelligence, space, civilian, energy and environmental markets. The company provides mission-critical services designed to help customers operate, maintain and modernize complex systems and infrastructure.

Its capabilities include systems engineering, program management, logistics, operations and maintenance, cybersecurity, digital transformation, intelligence analysis, testing and evaluation, and environmental and nuclear lifecycle services.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.